18 Results for "

MnSOD

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "MnSOD" in MCE Product Catalog:

3
3 Cited Publications
製品番号: HY-B0124
CAS 番号: 68291-97-4
別名: AD 810; CI 912
研究分野:  

Neurological Disease

Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy .
loading...
    loading...
2
2 Cited Publications
製品番号: HY-13336
CAS 番号: 218791-21-0
純度:  98.15%
別名: M40403; GC4403
Target:  

SOD

研究分野:  

Cancer

Imisopasem manganese (M40403) is a stable non-peptidyl mimetic of manganese superoxide MnSOD.
loading...
    loading...
製品番号: HY-125662A
CAS 番号: 1379783-91-1
BMX-001, a novel redox-active metalloporphyrin, improves islet function and engraftment in a murine transplant model. BMX-001 reduces apoptosis in human and murine islets. BMX-001 significantly improves static-glucose stimulated insulin secretion (sGSIS) responses in murine islets. BMX-001 can significantly restore euglycemia in murine islet studies in the presence of the MnSOD. BMX-001 reduces the generation of ROS in a murine islet isolation and culture model .
loading...
    loading...
製品番号: HY-B0124A
CAS 番号: 68291-98-5
別名: AD 810 sodium; CI 912 sodium
Zonisamide (AD 810) sodium is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide sodium exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide sodium also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide sodium can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy .
loading...
    loading...
製品番号: HY-124665
CAS 番号: 473870-63-2
LMP-420 is a selective tumor necrosis factor-α (TNF-α) inhibitor. LMP-420 reduces the release of pro-inflammatory cytokines (e.g., IL-1β, IL-2), inducing the expression of anti-inflammatory cytokine IL-10 and anti-apoptotic molecules SOCS-1 and Mn-SOD. LMP-420 also downregulates chemokines (e.g., IP-10, MCP-1) to reduce immune cell infiltration. LMP-420 is promising for research of type 1 diabetes mellitus, inflammatory diseases (e.g., colitis), and HIV-Mycobacterium tuberculosis coinfection .
loading...
    loading...
製品番号: HY-RS23382
研究分野:  

Others

Sod2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sod2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
製品番号: HY-RS13560
研究分野:  

Others

SOD2 Human Pre-designed siRNA Set A contains three designed siRNAs for SOD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
製品番号: HY-B0124R
CAS 番号: 68291-97-4
別名: AD 810 (Standard); CI 912 (Standard)
Zonisamide (Standard) is the analytical standard of Zonisamide. This product is intended for research and analytical applications. Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy .
loading...
    loading...
製品番号: HY-B0124S2
別名: AD 810-13C6; CI 912-13C6
Zonisamide- 13C6 (AD 810- 13C6) is 13C labeled Zonisamide. Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy .
loading...
    loading...
製品番号: HY-P83938
別名: IPOB; IPO-B; MnSOD; MVCD6; Mn-SOD

Host:  

Mouse

Application:  

WB, IHC-P, FC, ELISA

Reactivity:  

Human

loading...
    loading...
製品番号: HY-P83938A
別名: IPOB; IPO-B; MnSOD; MVCD6; Mn-SOD

Host:  

Mouse

Application:  

WB, IHC-P, FC, ELISA

Reactivity:  

Human

loading...
    loading...
製品番号: HY-P80898
別名: IPOB; IPO-B; MnSOD; MVCD6; Mn-SOD; SOD2

Host:  

Mouse

Application:  

WB

Reactivity:  

Human

loading...
    loading...
製品番号: HY-RS16939
研究分野:  

Others

Sod2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sod2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
製品番号: HY-P80898A
別名: IPOB; IPO-B; MnSOD; MVCD6; Mn-SOD; SOD2

Host:  

Mouse

Application:  

WB

Reactivity:  

Human

loading...
    loading...
製品番号: HY-P810660
別名: IPOB; IPO-B; MnSOD; MVCD6; Mn-SOD; SOD2

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
製品番号: HY-179151
研究分野:  

Cancer

CDK4/6-IN-26 is a carbamate derivative that targets CDK4/CDK6. CDK4/6-IN-26 reduces CDK4/CDK6 levels, resulting in cell cycle arrest in the G0/G1 phase and in the S phase. CDK4/6-IN-26 exhibits high potency against SW480 cells (IC50 = 6.3 μM). CDK4/6-IN-26 affects ROS levels by increasing the expression of SOD2/MnSOD. CDK4/6-IN-26 establishes several interactions with the amino acids of the CDK6 active site. CDK4/6-IN-26 can be used for the research of colorectal cancer .
loading...
    loading...
製品番号: HY-B0124S3
CAS 番号: 2308764-57-8
Zonisamide- 15N,d4 is the 15N- and deuterium labeled Zonisamide (HY-B0124). Zonisamide (AD 810) is an orally active carbonic anhydrase inhibitor, with Kis of 35.2 and 20.6 nM for hCA II and hCA V, respectively. Zonisamide exerts neuroprotective effects through anti-apoptosis and upregulating MnSOD levels. Zonisamide also increases the expression of Hrd1, thereby improving cardiac function in AAC rats. Zonisamide can be used in studies of seizure, parkinson’s disease and cardiac hypertrophy .
loading...
    loading...
製品番号: HY-183853
CAS 番号: 35516-99-5
Arecaidine-propargyl ester is a selective M2 muscarinic receptor agonist with blood-brain barrier permeability, with a pKi of 5.91 for hm1, 7.06 for hm2, 6.07 for hm3, 6.01 for hm4, and 6.03 for hm5. Arecaidine-propargyl ester stimulates central and peripheral muscarinic receptors. Arecaidine-propargyl ester increases intracellular ROS, induces DNA damage and Apoptosis, and upregulates the expression of MnSOD and SIRT1. Arecaidine-propargyl ester reduces sympathetic nerve outflow, induces dose-dependent hypotension, and triggers negative chronotropic effects at high peripheral doses. Arecaidine-propargyl ester can be used in research related to Alzheimer's disease and glioblastoma .
loading...
    loading...
  • 1